Lixte Biotechnology Holdings, Inc. Share Price
LIXTLixte Biotechnology Holdings, Inc. Stock Performance
Open $7.09 | Prev. Close $7.13 | Circuit Range N/A |
Day Range $7.09 - $8.13 | Year Range $0.68 - $8.13 | Volume 15,699 |
Average Traded $7.72 |
Lixte Biotechnology Holdings, Inc. Share Price Chart
About Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.
Lixte Biotechnology Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $7.09 | $8.06 | +0.00% |
29-Jun-26 | $7.09 | $8.06 | +12.73% |
26-Jun-26 | $6.75 | $7.15 | +7.52% |
25-Jun-26 | $6.75 | $6.65 | -3.90% |
24-Jun-26 | $6.68 | $6.92 | -3.89% |
23-Jun-26 | $7.22 | $7.20 | -3.29% |
22-Jun-26 | $7.54 | $7.45 | -1.65% |
FAQs on Lixte Biotechnology Holdings, Inc. Share Price
Can I buy Lixte Biotechnology Holdings, Inc. shares in India?
What is the share price of Lixte Biotechnology Holdings, Inc.?
What is the 5 year returns of Lixte Biotechnology Holdings, Inc.?
What are the high & low stock price of Lixte Biotechnology Holdings, Inc. today?
What is the 52-week high and low of Lixte Biotechnology Holdings, Inc. stock?